Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, February 11 '25)

Image
By G.M.

 


    BMC Pediatr

  1. KUDLACEK M, Fromel K, Groffik D, Mitas J, et al
    Individual physical activity preferences of adolescents in the Czech Republic and Poland: a 14-year comparative study reflecting the gender trends and prospective responses to global lifestyle challenges.
    BMC Pediatr. 2025;25:98.
    PubMed         Abstract available


    J Infect Dis

  2. GOYA S, Wendm ST, Xie H, Nguyen TV, et al
    Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021-2022.
    J Infect Dis. 2025;231:e154-e164.
    PubMed         Abstract available

  3. CHIME N, Anspach B, Jain V, Laajalahti O, et al
    Phase 3 Study Assessing Lot-to-lot Consistency of RSVPreF3 Vaccine and its Immune Response, Safety, and Reactogenicity When Co-administered with FLU-D-QIV.
    J Infect Dis. 2024 Jul 5:jiae342. doi: 10.1093.
    PubMed         Abstract available

  4. BARZAGHI F, Visconti C, Pipitone GB, Bondesan S, et al
    Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti-Type I Interferon Antibodies.
    J Infect Dis. 2025;231:e206-e212.
    PubMed         Abstract available

  5. NAIR MS, Luck MI, Huang Y, Sabo Y, et al
    Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro.
    J Infect Dis. 2025;231:e68-e76.
    PubMed         Abstract available

  6. PISANIC N, Antar AAR, Hetrich MK, Demko ZO, et al
    Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution.
    J Infect Dis. 2025;231:121-130.
    PubMed         Abstract available

  7. LIN LY, Gantner P, Li S, Su B, et al
    Unpredicted protective function of Fc-mediated inhibitory antibodies for HIV and SARS-CoV-2 vaccines.
    J Infect Dis. 2024 Sep 20:jiae464. doi: 10.1093.
    PubMed         Abstract available

  8. BONOMO EJ, Shah M
    Rights-Based Legal Considerations for Tuberculosis Isolation Practices in Community Settings in the Postpandemic Era.
    J Infect Dis. 2025;231:31-36.
    PubMed         Abstract available

  9. BUTT AA, Yan P, Abou-Samra AB, Shaikh OS, et al
    COVID-19 Disease Incidence and Severity in Previously Infected Unvaccinated Compared with Previously Uninfected Vaccinated Persons.
    J Infect Dis. 2024 Oct 8:jiae484. doi: 10.1093.
    PubMed         Abstract available

  10. CHEW KW, McGinley B, Moser C, Li JZ, et al
    Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
    J Infect Dis. 2025;231:131-136.
    PubMed         Abstract available

  11. BABU TM, Jackson LA, El Sahly HM
    Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration.
    J Infect Dis. 2024 Oct 16:jiae504. doi: 10.1093.
    PubMed         Abstract available

  12. LORENZ N, James A, Van Rooyen T, Paterson A, et al
    Decline of Antibodies to Major Viral and Bacterial Respiratory Pathogens During the COVID-19 Pandemic.
    J Infect Dis. 2025;231:e77-e81.
    PubMed         Abstract available

  13. DESCALZO MA, de Paula Junior FJ, Mallegas NV, Penayo E, et al
    Annual estimation of seasonal influenza burden in six South American countries: a retrospective analysis of SARInet surveillance data to inform policies.
    J Infect Dis. 2025 Feb 1:jiaf037. doi: 10.1093.
    PubMed         Abstract available

  14. JARA JH, Loayza S, Nogareda F, Couto P, et al
    Influenza vaccine averted illnesses in Chile, Guyana, and Paraguay during 2013-2018: a standardized approach to assess value of vaccination.
    J Infect Dis. 2025 Feb 1:jiaf038. doi: 10.1093.
    PubMed         Abstract available


    J Neurosurg Pediatr

  15. SALEH M, Lesha E, Nichols CS, Shimony N, et al
    A prospective observational study of operating room traffic during shunt surgery: who comes in and why?
    J Neurosurg Pediatr. 2024;35:167-173.
    PubMed         Abstract available


    J Virol

  16. PARK H, Kingstad-Bakke B, Cleven T, Jung M, et al
    Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein.
    J Virol. 2025 Feb 3:e0086724. doi: 10.1128/jvi.00867.
    PubMed         Abstract available


    Pediatrics

  17. MUKHOPADHYAY S, Kaufman DA, Saha S, Puopolo KM, et al
    Late-Onset Sepsis Among Extremely Preterm Infants During the COVID-19 Pandemic.
    Pediatrics. 2025 Jan 23:e2024067675. doi: 10.1542/peds.2024-067675.
    PubMed         Abstract available

  18. HE S, Esteban McCabe S, Conti RM, Volerman A, et al
    Prescription Stimulant Dispensing to US Children: 2017-2023.
    Pediatrics. 2025;155:e2024068558.
    PubMed         Abstract available


    PLoS Comput Biol

  19. LOMBARD B, Moultrie H, Pulliam JRC, van Schalkwyk C, et al
    Simulation-based validation of a method to detect changes in SARS-CoV-2 reinfection risk.
    PLoS Comput Biol. 2025;21:e1012792.
    PubMed         Abstract available


    PLoS Med

  20. BHATIA A, Preiss AJ, Xiao X, Brannock MD, et al
    Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C.
    PLoS Med. 2025;22:e1004493.
    PubMed         Abstract available

  21. RAGONNET R, Hughes AE, Shipman DS, Meehan MT, et al
    Estimating the impact of school closures on the COVID-19 dynamics in 74 countries: A modelling analysis.
    PLoS Med. 2025;22:e1004512.
    PubMed         Abstract available


    PLoS One

  22. GOYAL A, Saeed H, Sultan W, Singh A, et al
    Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
    PLoS One. 2025;20:e0317592.
    PubMed         Abstract available

  23. BIBI N, Shah M, Khan S, Chohan MS, et al
    Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry.
    PLoS One. 2025;20:e0310855.
    PubMed         Abstract available

  24. WARNER BM, Vendramelli R, Boese AS, Audet J, et al
    Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection.
    PLoS One. 2025;20:e0316952.
    PubMed         Abstract available

  25. SCHUITEMA G, Lacchia A
    From anxiety to coping: Understanding psychological distance and coping skills for climate change and COVID-19 in 10-12-year-old children.
    PLoS One. 2025;20:e0317725.
    PubMed         Abstract available

  26. SYKES BL, Chavez EK, Strong JD
    Death and disappearance: Measuring racial disparities in mortality and life expectancy among people in state prisons, United States 2000-2014.
    PLoS One. 2025;20:e0314197.
    PubMed         Abstract available

  27. ZHANG C, Liu S, Qin M, Gao B, et al
    The dependency structure of international commodity and stock markets after the Russia-Ukraine war.
    PLoS One. 2025;20:e0316288.
    PubMed         Abstract available

  28. FISCHER B, Farr M, Gummert J, Knabbe C, et al
    High-frequency PCR-testing as a powerful approach for SARS-CoV-2 surveillance in the field of critical infrastructure: A longitudinal, retrospective study in a German tertiary care hospital.
    PLoS One. 2025;20:e0317009.
    PubMed         Abstract available

  29. COROCHER T, Edwards K, Hersusianto Y, Campbell D, et al
    Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2.
    PLoS One. 2025;20:e0316700.
    PubMed         Abstract available

  30. ALUSTA P, Paredes A, Azevedo M, Mullis L, et al
    Direct detection and identification of viruses in saliva using a SpecID ionization modified mass spectrometer.
    PLoS One. 2025;20:e0316368.
    PubMed         Abstract available

  31. KOSTIC K, Kostic A, Petrovic A, Vasilijevic A, et al
    The Serbian version of the Pandemic-Related Pregnancy Stress Scale (PREPS-SRB)-A validation study.
    PLoS One. 2025;20:e0317909.
    PubMed         Abstract available

  32. SAFDARI A, Keshav CS, Mody D, Verma K, et al
    The external validity of machine learning-based prediction scores from hematological parameters of COVID-19: A study using hospital records from Brazil, Italy, and Western Europe.
    PLoS One. 2025;20:e0316467.
    PubMed         Abstract available

  33. ARTOIS J, Vergne T, Fourtune L, Dellicour S, et al
    Spatial risk modelling of highly pathogenic avian influenza in France: Fattening duck farm activity matters.
    PLoS One. 2025;20:e0316248.
    PubMed         Abstract available

  34. FUNK M, Reinke M, Lowe B, Engelmann P, et al
    Development of an expectation management intervention for patients with Long COVID: A focus group study with affected patients.
    PLoS One. 2025;20:e0317905.
    PubMed         Abstract available

  35. SPITERI S, Salamon I, Girolamini L, Pascale MR, et al
    Surfaces environmental monitoring of SARS-CoV-2: Loop mediated isothermal amplification (LAMP) and droplet digital PCR (ddPCR) in comparison with standard Reverse-Transcription quantitative polymerase chain reaction (RT-qPCR) techniques.
    PLoS One. 2025;20:e0317228.
    PubMed         Abstract available

  36. GANDJOUR A
    Health-economic evaluation of the outpatient, inpatient, and public health sector in Germany: Insights from the first three COVID-19 waves.
    PLoS One. 2025;20:e0314164.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  37. LIAO Y, Ma H, Wang Z, Wang S, et al
    Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.
    Proc Natl Acad Sci U S A. 2025;122:e2406659122.
    PubMed         Abstract available


    Vaccine

  38. HASHIMOTO M, Tsujii K, Nakajima-Yoshida H, Akiyama N, et al
    A-910823, a squalene-based emulsion adjuvant, enhances robust and broad immune responses of quadrivalent influenza vaccine in ferrets.
    Vaccine. 2025;49:126780.
    PubMed         Abstract available

  39. GE Y, Handel A, Giabbanelli PJ, Lemacks J, et al
    Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC study.
    Vaccine. 2025;49:126802.
    PubMed         Abstract available

  40. POWELL A, Jones A, Van Hout MC, Montgomery C, et al
    Influenza vaccine uptake in socially deprived areas: A multilevel retrospective population-based cross-sectional study using electronic health records in Liverpool, United Kingdom.
    Vaccine. 2025;50:126837.
    PubMed         Abstract available

  41. SOENS M, Ananworanich J, Hicks B, Lucas KJ, et al
    A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults.
    Vaccine. 2025;50:126847.
    PubMed         Abstract available


    Virology

  42. POPOVIC ME, Tadic V, Popovic M
    (R)evolution of Viruses: Introduction to biothermodynamics of viruses.
    Virology. 2025;603:110319.
    PubMed         Abstract available

  43. YANG S, Yang X, Zhu W, Luo C, et al
    The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.
    Virology. 2024;603:110334.
    PubMed         Abstract available

  44. ROY K, Saikia BK, Konwar R
    Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus.
    Virology. 2025;603:110339.
    PubMed         Abstract available

  45. JONES LR
    Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19.
    Virology. 2025;603:110366.
    PubMed         Abstract available

  46. CALDERON-PEREZ B, Nunez-Munoz LA, Trejo-Ayala LL, Rosales-Garcia VH, et al
    Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants.
    Virology. 2024;603:110380.
    PubMed         Abstract available

  47. ZHAO Y, Li W, Xu L, Tao Z, et al
    Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2.
    Virology. 2025;603:110404.
    PubMed         Abstract available

  48. MILLER JL, Niewiesk S
    Review of impaired immune parameters in RSV infections in the elderly.
    Virology. 2025;603:110395.
    PubMed         Abstract available

  49. ZHIRNOV OP, Chernyshova AI
    The uncleaved viral hemagglutinin HA0 increases influenza A virus resistance to thermal pasteurization.
    Virology. 2025;604:110389.
    PubMed         Abstract available


    Virus Res

  50. CHA RM, Park MJ, Baek YG, Lee YN, et al
    Genetic characteristics and pathogenesis of clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus isolated from poultry in South Korea, 2022-2023.
    Virus Res. 2025 Jan 31:199541. doi: 10.1016/j.virusres.2025.199541.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

By G.M.
On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...
Post a Comment
Read more »

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

By G.M.
Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...
Post a Comment
Read more »

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

By G.M.
 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...
Post a Comment
Read more »